Are newer antidepressants really "better tolerated"? [3]

Canadian Journal of Psychiatry

Volumn 46, Issue 3, 2001, Pages 286-287

  Robinson, M J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGITATION; ANXIETY NEUROSIS; CASE REPORT; DEPRESSION; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; LETTER; ORTHOSTATIC HYPERTENSION; SEXUAL DYSFUNCTION; SIDE EFFECT; SWEATING; TACHYCARDIA; XEROSTOMIA;

EID: 0035014891     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370104600314     Document Type: Letter

References (4)

1. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of actions
2. Problems with currently available antidepressants
3. Management of nonresponse and intolerance: Switching strategies
4. Venlafaxine and vivid dreaming